BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4262004)

  • 1. Lymphocyte antigens in patients with Down's syndrome.
    Boxer LA; Yokoyama M
    Vox Sang; 1972; 22(6):539-43. PubMed ID: 4262004
    [No Abstract]   [Full Text] [Related]  

  • 2. The HL-A leucocyte system in Down's syndrome.
    Harris R; Timson J; Wentzel J
    Transplant Proc; 1969 Mar; 1(1):122-3. PubMed ID: 4257479
    [No Abstract]   [Full Text] [Related]  

  • 3. HL-A frequencies in Down's syndrome.
    Segal DJ; Schlaut JW; Pabst HF; McCoy EE; Dossetor JB
    Humangenetik; 1975; 27(1):45-8. PubMed ID: 124700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease.
    Grumet FC; Coukell A; Bodmer JG; Bodmer WF; McDevitt HO
    N Engl J Med; 1971 Jul; 285(4):193-6. PubMed ID: 5087722
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies of Down's syndrome and Alzheimer's disease.
    Walford RL
    Ann N Y Acad Sci; 1982; 396():95-106. PubMed ID: 6295240
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucocyte migration in presence of leukaemia-associated antigens in children with Down's syndrome.
    Szigeti R; Révész T; Schuler D; Gerö-Ferencz E; Zsuráffy E
    Haematologia (Budap); 1976; 10(1):23-6. PubMed ID: 137841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphocyte subpopulations in Down's syndrome].
    Mori M; Zaike Y; Takeda T
    Rinsho Ketsueki; 1986 Oct; 27(10):1829-33. PubMed ID: 2950258
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to thymocytes in the serum of Down's syndrome patients].
    Domashneva IV; Shvarts EI; Kushner SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1424-7. PubMed ID: 158926
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylcholine receptor antibodies in the elderly and in Down's syndrome.
    Robb SA; Vincent A; McGregor MA; McGregor AM; Newsom-Davis JM
    J Neuroimmunol; 1985 Aug; 9(3-4):139-46. PubMed ID: 3160723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity and ultrastructure in myeloproliferative reactions in infants with Down's syndrome.
    Miale TD; Nasrallah AG; Lobel SA; Demian S; Bowman WP
    Am J Pediatr Hematol Oncol; 1986; 8(3):191-9. PubMed ID: 2945495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.
    Barrena MJ; Echaniz P; Garcia-Serrano C; Zubillaga P; Cuadrado E
    Clin Exp Immunol; 1992 Apr; 88(1):41-4. PubMed ID: 1348667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celiac disease in Down's syndrome: considerations on the role of histocompatibility antigens.
    Iacono G; Cavataio F; Balsamo V; Carroccio A; Montalto G; Notarbartolo A
    J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):273. PubMed ID: 2137535
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral and cellular immunity in simple trisomy 21--Down's syndrome].
    Getlík A; Páleníková O; Stubna J
    Bratisl Lek Listy; 1985 Jun; 83(6):598-604. PubMed ID: 3160434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic and virologic studies in Down's syndrome].
    György F; Gizella K; Pál D; István N; Dezsö S; Matild D
    Orv Hetil; 1978 May; 119(19):1147-51. PubMed ID: 206865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.